Vous avez cherché: inhibitorer (Suédois - Anglais)

inhibitorer
inhibitor

inhibitorer har
patients treated with

anodiska inhibitorer
anodic inhibitor

cyp3a4- inhibitorer:
cyp3a4 inhibitors:

patienter med inhibitorer
patients with inhibitors

faktor viii- inhibitorer ptp
factor viii inhibitors - ptps

inhibitorer av p- glykoprotein:
p- glycoprotein inhibitors:

ace- inhibitorer kan sänka blodsockernivån.
ace-inhibitors may decrease the blood glucose levels.

ingen av patienterna utvecklade inhibitorer.
none of the patients developed inhibitors.

utveckling av neutraliserande antikroppar (inhibitorer)
development of neutralising antibodies (inhibitors)

risken att utveckla inhibitorer är korrelerad till
these inhibitors are usually igg immunoglobulins directed against the factor viii procoagulant activity, which are quantified in bethesda units (bus) per ml of plasma using the nijmegen modification of the bethesda assay.

beskrivning av valda biverkningar utveckling av inhibitorer
description of selected adverse reactions inhibitor development

vissa potatissorter innehåller flera inhibitorer än andra.
some potato cultivars contain more inhibitors than others.

färre än 0, 2% ptp utvecklade de- novo inhibitorer.
less than 0.2% ptp developed de-novo inhibitors.

totalt 9 av 60 patienter (15 %) utvecklade inhibitorer.
overall, 9 out of 60 (15%) developed inhibitors.

patienterna bör övervakas beträffande utveckling av faktor ix inhibitorer.
patients should be monitored for the development of factor ix inhibitors.

i sällsynta fall kan inhibitorer utvecklas efter mer än 100 exponeringsdagar.
rarely, inhibitors may develop after the first 100 exposure days.

i sällsynta fall kan inhibitorer utvecklas efter de första 100 exponeringsdagarna.
rarely inhibitors may develop after the first 100 exposure days.

utveckling av inhibitorer advates immunogenicitet utvärderades hos tidigare behandlade patienter.
16 inhibitor development the immunogenicity of advate was evaluated in previously treated patients.

patienterna bör monitoreras med avseende på utveckling av faktor viii- inhibitorer.
patients should be monitored for the development of factor viii inhibitors.